Essential roles of VLA-4 in the hematopoietic system

被引:0
|
作者
Yoichi Imai
Motomu Shimaoka
Mineo Kurokawa
机构
[1] University of Tokyo,Department of Hematology and Oncology, Graduate School of Medicine
[2] Harvard Medical School,Immune Disease Institute, Children’s Hospital Boston
来源
关键词
Integrin; VLA-4; Hematopoiesis; Chemotherapy sensitivity; Mobilization;
D O I
暂无
中图分类号
学科分类号
摘要
Integrins are one of the major families of adhesion molecules and make various kinds of biological effects by mediating cell–cell and cell–matrix interactions. Among integrins, VLA-4 is expressed on many types of hematopoietic cells including stem/progenitor cells and it is considered as a critical regulator of adult hematopoiesis. Recent studies revealed that VLA-4 is not necessarily required for the development or maintenance of adult hematopoietic cells. On the other hand, it was proved that VLA-4 is essential for homeostasis of distribution of hematopoietic stem/progenitor cells (HSPCs) and mature lymphocytes in the body. The dynamic regulation of VLA-4 function is mediated by its conformational change, which is strictly linked to the interaction between α and β cytoplasmic domains. The study using knockin mice showed that GFFKR sequence, a well-preserved motif in the α cytoplasmic domain of VLA-4, is critical for binding of α and β cytoplasmic domains as well as regulation of hematopoietic cell distribution. Small molecules targeting this cytoplasmic interaction or ligand–VLA-4 interaction may become good candidates of new drugs for mobilization of hematopoietic stem cells. Several studies have suggested the impact of VLA-4 on chemotherapy sensitivity and prognosis in hematological malignancies, which awaits further investigations.
引用
收藏
页码:569 / 575
页数:6
相关论文
共 50 条
  • [1] Essential roles of VLA-4 in the hematopoietic system
    Imai, Yoichi
    Shimaoka, Motomu
    Kurokawa, Mineo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (04) : 569 - 575
  • [2] Functional roles for VLA-4 expressed on human neutrophils
    Reinhardt, PH
    Elliott, J
    Niu, XF
    Kubes, P
    FASEB JOURNAL, 1996, 10 (03): : 3537 - 3537
  • [3] VLA-4 antagonists
    Tilley, JW
    Sidduri, A
    DRUGS OF THE FUTURE, 2001, 26 (10) : 985 - 998
  • [4] Antagonists of VLA-4
    Holland, GW
    Biediger, RJ
    Vanderslice, P
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 65 - 74
  • [5] VLA-4 antagonists
    Tilley, JW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (07) : 991 - 1008
  • [6] FIBRONECTIN AND VLA-4 IN HEMATOPOIETIC STEM-CELL MICROENVIRONMENT INTERACTIONS
    WILLIAMS, DA
    RIOS, M
    STEPHENS, C
    PATEL, VP
    NATURE, 1991, 352 (6334) : 438 - 441
  • [7] The discovery of VLA-4 antagonists
    Tilley, JW
    Chen, L
    Sidduri, A
    Fotouhi, N
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (14) : 1509 - 1523
  • [8] VLA-4 antibody down regulates VLA-4 expression on stimulated human T cells
    Blake, JT
    Shah, K
    Matheravidathu, S
    Koo, GC
    FASEB JOURNAL, 2000, 14 (06): : A1141 - A1141
  • [9] Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
    M P Rettig
    G Ansstas
    J F DiPersio
    Leukemia, 2012, 26 : 34 - 53
  • [10] Effect of Natalizumab Dosing Frequency on VLA-4 Saturation and Surface Expression of VLA-4 on Lymphocyte Populations
    Rose, Deja R.
    Gallardo, Divina
    Leist, Thomas P.
    Johanson, Roy A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 66 - 67